Search results
Showing 1036 to 1050 of 1516 results for patients and public
In development Reference number: GID-TA11235 Expected publication date: TBC
In development Reference number: GID-HTE10070 Expected publication date: TBC
Leriglitazone for treating cerebral adrenoleukodystrophy in boys and men 2 years and over [ID3903]
In development Reference number: GID-TA11445 Expected publication date: TBC
In development Reference number: GID-HTE10079 Expected publication date: 27 January 2027
Percutaneous insertion of a cerebral protection device during TAVI for preventing stroke
In development Reference number: GID-IPG10439 Expected publication date: TBC
We are listening to your views on this Interventional procedures guidance. Comments close 19 February 2026.
Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.
Cenobamate for treating focal onset seizures in epilepsy (TA753)
Evidence-based recommendations on cenobamate (Ontozry) for treating focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has not been adequately controlled with at least 2 antiseizure medicines.
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.
Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery.
Evidence-based recommendations on relugolix–estradiol–norethisterone acetate (Ryeqo) for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Evidence-based recommendations on automated percutaneous mechanical lumbar discectomy. This involves using an automated device to cut and remove the part of the disc that’s pressing on the nerve.
View recommendations for HTG88Show all sections
Sections for HTG88
Laparoscopic insertion of peritoneal dialysis catheter (HTG133)
Evidence-based recommendations on laparoscopic insertion of peritoneal dialysis catheter. This involves inserting a tube through small cuts (keyhole surgery) in the abdomen to remove waste product from the blood.
View recommendations for HTG133Show all sections
Sections for HTG133